No Correlation of Substantia Nigra Echogenicity and Nigrostriatal Degradation in Parkinson's Disease
Identifieur interne : 001048 ( Main/Exploration ); précédent : 001047; suivant : 001049No Correlation of Substantia Nigra Echogenicity and Nigrostriatal Degradation in Parkinson's Disease
Auteurs : Elmar Lobsien [Allemagne] ; Simon Schreiner [Allemagne] ; Michail Plotkin [Allemagne] ; Andreas Kupsch [Allemagne] ; Stephan J. Schreiber [Allemagne] ; Florian Doepp [Allemagne]Source :
- Movement disorders [ 0885-3185 ] ; 2012.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Background: Substantia nigra hyperechogenicity assessed by transcranial sonography is a typical finding in up to 90% of patients with idiopathic Parkinson's disease, although its value as a surrogate marker for disease progression in Parkinson's disease is controversial. 123I-FP-CIT-single photon emission computed tomography (SPECT) represents an established para-clinical surrogate marker to quantify the nigrostriatal dopaminergic deficit in Parkinson's disease. Whereas most studies found no correlation between extent of substantia nigra echogenicity and the putaminal FP-CIT binding ratio, a more recent analysis reported opposite results. Methods: In 92 patients with Parkinson's disease the substantia nigra echogenicity was compared with the putaminal FP-CIT binding ratio using an investigator-independent SPECT analysis protocol and with several clinical parameters. Results: No correlation was found between the substantia nigra hyperechogenicity and the FP-CIT binding ratio or the disease severity. Conclusions: Substantia nigra hyperechogenicity does not reflect the degree of the nigrostriatal degeneration or the clinical state of the disease progression.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000206
- to stream PascalFrancis, to step Curation: 002B08
- to stream PascalFrancis, to step Checkpoint: 000121
- to stream Main, to step Merge: 001100
- to stream Main, to step Curation: 001048
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">No Correlation of Substantia Nigra Echogenicity and Nigrostriatal Degradation in Parkinson's Disease</title>
<author><name sortKey="Lobsien, Elmar" sort="Lobsien, Elmar" uniqKey="Lobsien E" first="Elmar" last="Lobsien">Elmar Lobsien</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schreiner, Simon" sort="Schreiner, Simon" uniqKey="Schreiner S" first="Simon" last="Schreiner">Simon Schreiner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Plotkin, Michail" sort="Plotkin, Michail" uniqKey="Plotkin M" first="Michail" last="Plotkin">Michail Plotkin</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Radiology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Radiology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kupsch, Andreas" sort="Kupsch, Andreas" uniqKey="Kupsch A" first="Andreas" last="Kupsch">Andreas Kupsch</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schreiber, Stephan J" sort="Schreiber, Stephan J" uniqKey="Schreiber S" first="Stephan J." last="Schreiber">Stephan J. Schreiber</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Doepp, Florian" sort="Doepp, Florian" uniqKey="Doepp F" first="Florian" last="Doepp">Florian Doepp</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0198699</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0198699 INIST</idno>
<idno type="RBID">Pascal:12-0198699</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000206</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002B08</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000121</idno>
<idno type="wicri:doubleKey">0885-3185:2012:Lobsien E:no:correlation:of</idno>
<idno type="wicri:Area/Main/Merge">001100</idno>
<idno type="wicri:Area/Main/Curation">001048</idno>
<idno type="wicri:Area/Main/Exploration">001048</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">No Correlation of Substantia Nigra Echogenicity and Nigrostriatal Degradation in Parkinson's Disease</title>
<author><name sortKey="Lobsien, Elmar" sort="Lobsien, Elmar" uniqKey="Lobsien E" first="Elmar" last="Lobsien">Elmar Lobsien</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schreiner, Simon" sort="Schreiner, Simon" uniqKey="Schreiner S" first="Simon" last="Schreiner">Simon Schreiner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Plotkin, Michail" sort="Plotkin, Michail" uniqKey="Plotkin M" first="Michail" last="Plotkin">Michail Plotkin</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Radiology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Radiology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kupsch, Andreas" sort="Kupsch, Andreas" uniqKey="Kupsch A" first="Andreas" last="Kupsch">Andreas Kupsch</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schreiber, Stephan J" sort="Schreiber, Stephan J" uniqKey="Schreiber S" first="Stephan J." last="Schreiber">Stephan J. Schreiber</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Doepp, Florian" sort="Doepp, Florian" uniqKey="Doepp F" first="Florian" last="Doepp">Florian Doepp</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>University-Medicine Berlin</wicri:noRegion>
<wicri:noRegion>Department of Neurology, Nuclear Medicine and Radiation Oncology, Charité, University-Medicine Berlin</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Locus niger</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Photon</term>
<term>Single photon emission tomography</term>
<term>Sonography</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Locus niger</term>
<term>Tomoscintigraphie émission monophotonique</term>
<term>Photon</term>
<term>Exploration ultrason</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Substantia nigra hyperechogenicity assessed by transcranial sonography is a typical finding in up to 90% of patients with idiopathic Parkinson's disease, although its value as a surrogate marker for disease progression in Parkinson's disease is controversial. <sup>123</sup>
I-FP-CIT-single photon emission computed tomography (SPECT) represents an established para-clinical surrogate marker to quantify the nigrostriatal dopaminergic deficit in Parkinson's disease. Whereas most studies found no correlation between extent of substantia nigra echogenicity and the putaminal FP-CIT binding ratio, a more recent analysis reported opposite results. Methods: In 92 patients with Parkinson's disease the substantia nigra echogenicity was compared with the putaminal FP-CIT binding ratio using an investigator-independent SPECT analysis protocol and with several clinical parameters. Results: No correlation was found between the substantia nigra hyperechogenicity and the FP-CIT binding ratio or the disease severity. Conclusions: Substantia nigra hyperechogenicity does not reflect the degree of the nigrostriatal degeneration or the clinical state of the disease progression.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
</list>
<tree><country name="Allemagne"><noRegion><name sortKey="Lobsien, Elmar" sort="Lobsien, Elmar" uniqKey="Lobsien E" first="Elmar" last="Lobsien">Elmar Lobsien</name>
</noRegion>
<name sortKey="Doepp, Florian" sort="Doepp, Florian" uniqKey="Doepp F" first="Florian" last="Doepp">Florian Doepp</name>
<name sortKey="Kupsch, Andreas" sort="Kupsch, Andreas" uniqKey="Kupsch A" first="Andreas" last="Kupsch">Andreas Kupsch</name>
<name sortKey="Plotkin, Michail" sort="Plotkin, Michail" uniqKey="Plotkin M" first="Michail" last="Plotkin">Michail Plotkin</name>
<name sortKey="Schreiber, Stephan J" sort="Schreiber, Stephan J" uniqKey="Schreiber S" first="Stephan J." last="Schreiber">Stephan J. Schreiber</name>
<name sortKey="Schreiner, Simon" sort="Schreiner, Simon" uniqKey="Schreiner S" first="Simon" last="Schreiner">Simon Schreiner</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001048 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001048 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:12-0198699 |texte= No Correlation of Substantia Nigra Echogenicity and Nigrostriatal Degradation in Parkinson's Disease }}
This area was generated with Dilib version V0.6.23. |